Andrew D. Dickinson
At a glance: Andrew D. Dickinson is CFO at Gilead Sciences (GILD). Their latest SEC Form 4, filed Nov 17, 2026, reported a sale of $514K. On file: 0 purchase lines ($0) and 14 sale lines ($5.7M).
Disclosed holdings: about $26.4M of GILD stock: 158,096 shares reported on their latest Form 4 (filed Nov 17, 2026), valued at the Nov 19, 2026 close of $167.13. This counts only GILD shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
CFO at Gilead Sciences, Inc. (GILD)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Andrew D. Dickinson's InsiderPrint
14 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 13 times a year, typically $415K a trade; most sales are on a pre-planned 10b5-1 schedule.
- Bump outward: a purchase (0)
- Dent inward: a sale (14)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Charles J. ProberDirector · LIF · 100% match
- Joseph B. ArmesCEO, President · CSW · 100% match
- Gary BowmanCEO · BWMN · 100% match
- Paul CunninghamPresident · CDNS · 100% match
- Rajesh PankajCTO · IDCC · 100% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 17SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000158,096 held (−2%) | $171.47 | $514K | -2.5% |
| Oct 16SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000161,096 held (−2%) | $156.22 | $469K | +7.0% |
| Sep 16SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000164,096 held (−2%) | $145.29 | $436K | +15.0% |
| Aug 18SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000165,646 held (−2%) | $138.36 | $415K | +20.8% |
| Jul 16SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000168,646 held (−2%) | $129.93 | $390K | +28.6% |
| Jun 16SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000171,646 held (−2%) | $125.40 | $376K | +33.3% |
| May 18SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000173,191 held (−2%) | $132.27 | $397K | +26.4% |
| Apr 16SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000176,191 held (−2%) | $140.96 | $423K | +18.6% |
| Mar 17SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000179,191 held (−2%) | $144.23 | $433K | +15.9% |
| Feb 18SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000167,779 held (−2%) | $154.43 | $463K | +8.2% |
| Jan 16SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000150,503 held (−2%) | $124.31 | $373K | +34.5% |
| Dec 16SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000153,503 held (−2%) | $122.00 | $366K | +37.0% |
| Nov 18SEC | GILDGilead Sciences, Inc. | Sell Plan | 2,500154,555 held (−2%) | $125.23 | $313K | +33.5% |
| Oct 16SEC | GILDGilead Sciences, Inc. | Sell Plan | 2,500157,055 held (−2%) | $118.08 | $295K | +41.5% |
- Sell
CFO Andrew D Dickinson sold $514K of GILD at $171.47 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Andrew D Dickinson sold $469K of GILD at $156.22 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Andrew D Dickinson sold $436K of GILD at $145.29 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Andrew D Dickinson sold $415K of GILD at $138.36 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Andrew D Dickinson sold $390K of GILD at $129.93 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Andrew D Dickinson sold $376K of GILD at $125.40 — pre-scheduled 10b5-1 plan sale.
Follow Andrew D. Dickinson
Get one email when Andrew D. Dickinson files a new purchase or sale. Free.
At most one email a day about Andrew D. Dickinson, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.